887906-32-3

Upstream product

• 887906-30-1 (S)-2-({2-[(S)-3-Cyano-3-((R)-2-hydroxy-1-phenyl-ethylamino)-propyl]-3-octyl-phenyl}-methyl-amino)-3-methyl-butyric acid benzyl ester 
• 67-56-1 methanol 
• 887906-20-9 acetic acid 3-(2-bromo-6-nitro-phenyl)-propyl ester 
• 887906-16-3 2-(2-bromo-6-nitro-benzyl)-malonic acid diethyl ester 
• 887906-28-7 3-(2-methylamino-6-octyl-phenyl)-propan-1-ol 
• 887906-27-6 acetic acid 3-(2-formylamino-6-octyl-phenyl)-propyl ester 
• 887906-23-2 acetic acid 3-(2-nitro-6-oct-1-ynyl-phenyl)-propyl ester 
• 887906-29-8 (S)-2-{[2-(3-Hydroxy-propyl)-3-octyl-phenyl]-methyl-amino}-3-methyl-butyric acid benzyl ester 
• 58579-54-7 3-bromo-2-(bromomethyl)-1-nitrobenzene 
• 55289-35-5 2-bromo-6-nitrotoluene 

Relevant academic research and scientific papers

Design and synthesis of 8-octyl-benzolactam-V9, a selective activator for protein kinase Cε and η

Conventional (α, βI, βII, γ) and novel (δ, ε, η, θ) protein kinase C (PKC) isozymes are main targets of tumor promoters, such as phorbol esters and indolactam-V (ILV). We have recently found that 1-hexyl derivatives of indolinelactam-V (2, 3), in which th